Predicting Treatment Discontinuation Among Patients with Multiple Sclerosis: Application of the Transtheoretical Model of Change
- 1 July 2004
- journal article
- Published by Elsevier in Journal of the American Pharmacists Association
- Vol. 44 (4) , 445-454
- https://doi.org/10.1331/1544345041475607
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Injectable medication for the treatment of multiple sclerosis: The influence of self-efficacy expectations and infection anxiety on adherence and ability to self-injectAnnals of Behavioral Medicine, 2001
- Multiple sclerosis: Empirical literature for the clinical health psychologistJournal of Clinical Psychology, 2001
- The ‘stages of change’ model in health promotion: Science and IdeologyCritical Public Health, 2000
- Telephone-administered cognitive–behavioral therapy for the treatment of depressive symptoms in multiple sclerosis.Journal of Consulting and Clinical Psychology, 2000
- Treatment adherence and patient retention in the first year of a Phase-III clinical trial for the treatment of multiple sclerosisMultiple Sclerosis Journal, 1999
- Treatment of Depression Improves Adherence to Interferon Beta-1b Therapy for Multiple SclerosisArchives of Neurology, 1997
- Therapeutic expectations of patients with multiple sclerosis upon initiating interferon beta-lb: Relationship to adherence to treatmentMultiple Sclerosis Journal, 1996
- Management of patients receiving interferon beta-1b for multiple sclerosisNeurology, 1996
- Criticisms and concerns of the transtheoretical model in light of recent researchBritish Journal of Addiction, 1992
- Depression as a major symptom of multiple sclerosis.Journal of Neurology, Neurosurgery & Psychiatry, 1980